Filing Details
- Accession Number:
- 0001883850-22-000092
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-08 16:00:44
- Reporting Period:
- 2022-11-04
- Accepted Time:
- 2022-11-08 16:00:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1411984 | P Daniel Plew Van | 777 Old Saw Mill River Road Tarrytown NY 10591 | Evp & General Mgr, Industrial | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-11-04 | 34,000 | $381.92 | 64,578 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-11-04 | 26,114 | $725.84 | 38,464 | No | 4 | F | Direct | |
Common Stock | Disposition | 2022-11-07 | 100 | $742.79 | 38,364 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-11-07 | 1,100 | $743.39 | 37,264 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-11-07 | 2,032 | $744.61 | 35,232 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-11-07 | 1,468 | $745.51 | 33,764 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-11-07 | 2,782 | $746.56 | 30,982 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-11-07 | 404 | $747.20 | 30,578 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2022-11-04 | 34,000 | $0.00 | 34,000 | $381.92 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2026-12-16 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,065 | Indirect | By 401(k) Plan |
Footnotes
- Represents volume-weighted average price of sales of 1,100 shares of Company stock on November 7, 2022 at prices ranging from $743.00 to $743.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2022 at each separate price.
- Represents volume-weighted average price of sales of 2,032 shares of Company stock on November 7, 2022 at prices ranging from $744.02 to $744.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2022 at each separate price.
- Represents volume-weighted average price of sales of 1,468 shares of Company stock on November 7, 2022 at prices ranging from $745.00 to $745.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2022 at each separate price.
- Represents volume-weighted average price of sales of 2,782 shares of Company stock on November 7, 2022 at prices ranging from $746.15 to $746.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2022 at each separate price.
- Represents volume-weighted average price of sales of 404 shares of Company stock on November 7, 2022 at prices ranging from $747.00 to $747.43. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2022 at each separate price.
- The stock option award vests in four equal annual installments, commencing one year after the date of grant.